- Home
- STRR vs BGLC Comparison
STRR vs BGLC Comparison
Compare STRR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- BGLC
- Stock Information
- Founded
- STRR 1985
- BGLC 2017
- Country
- STRR United States
- BGLC Malaysia
- Employees
- STRR N/A
- BGLC N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BGLC Medical Specialities
- Sector
- STRR Health Care
- BGLC Health Care
- Exchange
- STRR Nasdaq
- BGLC Nasdaq
- Market Cap
- STRR 7.0M
- BGLC 5.8M
- IPO Year
- STRR N/A
- BGLC N/A
- Fundamental
- Price
- STRR $2.33
- BGLC $0.25
- Analyst Decision
- STRR
- BGLC
- Analyst Count
- STRR 0
- BGLC 0
- Target Price
- STRR N/A
- BGLC N/A
- AVG Volume (30 Days)
- STRR 9.6K
- BGLC 1.5M
- Earning Date
- STRR 03-20-2025
- BGLC 05-14-2025
- Dividend Yield
- STRR N/A
- BGLC N/A
- EPS Growth
- STRR N/A
- BGLC N/A
- EPS
- STRR N/A
- BGLC N/A
- Revenue
- STRR $53,359,000.00
- BGLC $9,259,858.00
- Revenue This Year
- STRR $35.15
- BGLC N/A
- Revenue Next Year
- STRR $15.84
- BGLC N/A
- P/E Ratio
- STRR N/A
- BGLC N/A
- Revenue Growth
- STRR 16.54
- BGLC N/A
- 52 Week Low
- STRR $2.05
- BGLC $0.21
- 52 Week High
- STRR $5.35
- BGLC $1.00
- Technical
- Relative Strength Index (RSI)
- STRR 50.06
- BGLC 35.57
- Support Level
- STRR $2.30
- BGLC $0.23
- Resistance Level
- STRR $2.84
- BGLC $0.29
- Average True Range (ATR)
- STRR 0.23
- BGLC 0.02
- MACD
- STRR -0.01
- BGLC -0.01
- Stochastic Oscillator
- STRR 28.21
- BGLC 20.22
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.